Does intraoperative ulinastatin improve postoperative clinical outcomes in patients undergoing cardiac surgery: A meta-analysis of randomized controlled trials

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  He, Qiu Lan ^a   Zhong, Fei ^b,c   Ye, Fang ^a   Wei, Ming ^a   Liu, Wei Feng ^a   Li, Mei Na ^a   Li, Qiao Bo ^a   Huang, Wen Qi ^a   Sun, Lai Bao ^a   Shu, Hai Hua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; CREATINE KINASE MB; GLYCOPROTEIN; LEUKOCYTE ELASTASE; OXYGEN; TRYPSIN INHIBITOR;

EXTUBATION; HEART INDEX; HEART SURGERY; HUMAN; LUNG FUNCTION; META ANALYSIS; NEUTROPHIL; OUTCOME ASSESSMENT; OXYGENATION; POSTOPERATIVE CARE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; BLOOD; CHEMISTRY; INFLAMMATION; INTENSIVE CARE; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MORTALITY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROCEDURES; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CREATINE KINASE, MB FORM; GLYCOPROTEINS; HOSPITAL MORTALITY; HUMANS; INFLAMMATION; INTENSIVE CARE; INTERLEUKIN-6; INTERLEUKIN-8; INTRAOPERATIVE PERIOD; LENGTH OF STAY; LEUKOCYTE ELASTASE; OXYGEN; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TROPONIN I; TRYPSIN INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897494016     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/630835     Document Type: Review

References (70)

1. Rossaint J., Berger C., van Aken H., Scheld H. H., Zahn P. K., Rukosujew A., Zarbock A., Cardiopulmonary bypass during cardiac surgery modulates systemic inflammation by affecting different steps of the leukocyte recruitment cascade. PLoS ONE 2012 7 9 e45738 10.1371/journal.pone.0045738
2. Munger M. A., Johnson B., Amber I. J., Callahan K. S., Gilbert E. M., Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. The American Journal of Cardiology 1996 77 9 723 727 2-s2.0-0029912883 10.1016/S0002-9149(97)89206-5 (Pubitemid 26116687)
3. Tentolouris C., Tousoulis D., Antoniades C., Bosinakou E., Kotsopoulou M., Trikas A., Toutouzas P., Stefanadis C., Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. International Journal of Cardiology 2004 94 2-3 301 305 2-s2.0-1842850657 10.1016/j.ijcard.2003.08.002 (Pubitemid 38490677)
4. Yang Y. L., Huang K. L., Liou H. L., Chen H. I., The involvement of nitric oxide, nitric oxide synthase, neutrophil elastase, myeloperoxidase and proinflammatory cytokines in the acute lung injury caused by phorbol myristate acetate. Journal of Biomedical Science 2008 15 4 499 507 2-s2.0-44949254934 10.1007/s11373-008-9238-y
5. Holmes J. H., Connolly N. C., Paull D. L., Hill M. E., Guyton S. W., Ziegler S. F., Hall R. A., Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflammation Research 2002 51 12 579 586 2-s2.0-0036969262 10.1007/PL00012432 (Pubitemid 36140268)
6. Sun T. S., Chen X. B., Liu Z., Ma Z. Y., Zhang J. Z., Relationship between the operation time of multiple fractures with system inflammation changes and clinical outcomes. Zhonghua Wai Ke Za Zhi 2008 46 13 961 965 2-s2.0-64849089457
7. Gentile L. F., Cuenca A. G., Efron P. A., Ang D., Bihorac A., McKinley B. A., Moldawer L. L., Moore F. A., Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. Journal of Trauma and Acute Care Surgery 2012 72 6 1491 1501 10.1097/TA.0b013e318256e000
8. Hirose J., Ozawa T., Miura T., Isaji M., Nagao Y., Yamashiro K., Nii A., Kato K., Uemura A., Human neutrophil elastase degrades inter- α -trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biological and Pharmaceutical Bulletin 1998 21 7 651 656 2-s2.0-0031877808 (Pubitemid 28374433)
9. Zhou Q., Wang G., Gao C., Chen T., Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010 35 2 107 110 2-s2.0-77949857334 10.3969/j.issn.1672-7347.2010.02.003
10. Yu X. Y., Fan L. L., Effects of different doses of ulinastatin on inflammatory response and pulmonary function after cardiopulmonary bypass. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2009 21 11 664 667 2-s2.0-73349099356 10.3760Zcma.j.issn.1003-0603.2009.11.009
11. Shen J. M., Li L., He X. J., Effects of ulinastatin on erythrocyte lipid peroxidation in patients undergoing open heart surgery. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2004 29 2 187 189 2-s2.0-39049181631
12. Kawamura T., Inada K., Kimura O., Akasaka N., Wakusawa R., The inhibitory effects of ulinastatin on the increase of interleukin 8 and 6 during open heart surgery. Masui 1994 43 12 1818 1823 2-s2.0-0028625416
13. Kawai T., Wada Y., Nishiyama K., Kanki Y., Ohga K., Oka T., Yasuda M., Yoshikawa T., Usefulness of ulinastatin as a radical scavenger for protection of reperfusion injury after myocardial ischemia in open heart surgery. Journal of the Japanese Association for Thoracic Surgery 1991 39 12 2157 2162 2-s2.0-0026338762
14. Kawamura T., Inada K., Akasaka N., Wakusawa R., Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Canadian Journal of Anaesthesia 1996 43 5 I 456 460 2-s2.0-0029996808 (Pubitemid 26180455)
15. Inoue K., Takano H., Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders. Expert Opinion on Investigational Drugs 2010 19 4 513 520 2-s2.0-77952492404 10.1517/13543781003649533
16. Han J. I., Urinary trypsin inhibitor: miraculous medicine in many surgical situations? Korean Journal of Anesthesiology 2010 58 4 325 327 2-s2.0-77953419340 10.4097/kjae.2010.58.4.325
17. Higgins J. P. T., Green S., Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 2011 The Cochrane Collaboration
18. Moher D., Liberati A., Tetzlaff J., Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. PLoS Medicine 2009 6 7 e1000097 10.1371/journal.pmed.1000097
19. Zhang L., Ajiferuke I., Sampson M., Optimizing search strategies to identify randomized controlled trials in MEDLINE. BMC Medical Research Methodology 2006 6, article 23 2-s2.0-33745771407 10.1186/1471-2288-6-23 (Pubitemid 44020214)
20. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J. M., Gavaghan D. J., McQuay H. J., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 17 1 1 12 2-s2.0-0029914622 10.1016/0197-2456(95)00134-4 (Pubitemid 26120810)
21. Egger M., Smith G. D., Schneider M., Minder C., Bias in meta-analysis detected by a simple, graphical test. The British Medical Journal 1997 315 7109 629 634 2-s2.0-0030922816 (Pubitemid 27387172)
22. Jiang Y. F., Wang W. W., Ye W. L., Ni Y., Li J., Chen X., Jin S., Lian Q., Effects of alprostadil and ulinastatin on inflammatory response and lung injury after cardiopulmonary bypass in pediatric patients with congenital heart diseases. Zhonghua Yi Xue Za Zhi 2008 88 41 2893 2897 2-s2.0-66049161861
23. Mishima A., Takeuti Y., Usami S., Kotani H., Suzuki Y., Yura J., Effects of ulinastatin on plasma polymorphonuclear leukocyte elastase activity and respiratory function in patients undergoing cardiopulmonary bypass. Nihon Kyobu Geka Gakkai Zasshi 1990 38 4 607 612 2-s2.0-0025302354 (Pubitemid 20202853)
24. Ren T. Y., Yang X. W., Ma Y., Wang F., Qiang W. D., Myocardial protective effect of ulinastatin against ischemia/reperfusion injury during open heart surgery with cardiopulmonary bypass. Zhonghua Yi Xue Za Zhi 2003 83 16 1391 1393 2-s2.0-1542702826
25. Wang G. Y., Qiu H. B., Zhan S. G., Li L. H., Protection of ulinastatin against myocardial injury induced by off-pump coronary artery bypass graft surgery: report of 24 cases. Zhonghua Yi Xue Za Zhi 2007 87 35 2502 2504 2-s2.0-37149021588
26. Wang D. J., Liu J. X., Yin B. L., Protective effects of ulinastatin on the lung injury during cardiopulmonary bypass. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005 30 6 670 672 2-s2.0-30744449967
27. Zhang X., Qin X. G., Effect of ulinastatin on cardiac and lung function of patients with moderate and high risk in cardiac surgery under cardiopulmonary bypass. Modern Preventive Medicine 2012 7 1822 1824
28. Oh S. Y., Kim J. C., Choi Y. S., Lee W. K., Lee Y. K., Kwak Y. L., Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass. Korean Journal of Anesthesiology 2012 62 2 148 153 2-s2.0-84857674369 10.4097/kjae.2012.62.2. 148
29. Nakanishi K., Takeda S., Sakamoto A., Kitamura A., Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction. Critical Care Medicine 2006 34 5 1351 1357 2-s2.0-33646591214 10.1097/01.CCM.0000215110.55899.AE
30. Bingyang J., Jinping L., Mingzheng L., Guyan W., Zhengyi F., Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response. Journal of Cardiovascular Surgery 2007 48 4 497 503 2-s2.0-35848933466 (Pubitemid 350055024)
31. Sato Y., Ishikawa S., Otaki A., Takahashi T., Hasegawa Y., Suzuki M., Yamagishi T., Morishita Y., Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury. The Japanese Journal of Thoracic and Cardiovascular Surgery 2000 48 7 428 434 2-s2.0-0034219017
32. Tu H. Q., Ming T., Postoperative application of ulinastatin in infants with critical congenital heart disease. Journal of Nanchang University (Medical Science) 2011 51 2 37 40
33. Song J. E., Kang W. S., Kim D. K., Yoon T. G., Kim T. Y., Bang Y., Kim S. H., The effect of ulinastatin on postoperative blood loss in patients undergoing open heart surgery with cardiopulmonary bypass. Journal of International Medical Research 2011 39 4 1201 1210 2-s2.0-80052224208
34. Li J., Wang Z., Xu Z., Huang S., Qiao F., The role of ulinastatin in management of systemic inflammatory response syndrome post-CPB. Internationl Journal of Emergency and Critical Car 2007 4 4 1929 1933
35. Song J., Park J., Kim J. Y., Kim J. D., Kang W. S., Muhammad H. B., Kwon M. Y., Kim S. H., Yoon T. G., Kim T. Y., Chung J. W., Effect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: a randomized double-blinded study. Korean Journal of Anesthesiology 2013 64 4 334 340 10.4097/kjae.2013.64.4.334
36. Chong E. X., Zou C. W., Zhang M. Y., Guo L., Effects of high-dose ulinastatin on inflammatory response and pulmonary function in patients with type-A aortic dissection after cardiopulmonary bypass under deep hypothermic circulatory arrest. Journal of Cardiothoracic and Vascular Anesthesia 2013 27 3 479 484 10.1053/j.jvca.2012.11.001
37. Hiyama A., Takeda J., Kotake Y., Morisaki H., Fukushima K., A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 1997 11 5 580 584 2-s2.0-0030769416 10.1016/S1053-0770(97) 90008-2 (Pubitemid 27332936)
38. Sato N., Murakami K., Ishida K., Ikeda K., Saito K., Pulmonary hypertension and polymorphonuclear leukocyte elastase after esophageal cancer operations. Annals of Thoracic Surgery 1991 51 5 754 758 2-s2.0-0026007126
39. Sato A., Kuwabara Y., Shinoda N., Kimura M., Ishiguro H., Fujii Y., Use of low dose dopamine, gabexate mesilate and ulinastatin reduces the water balance and pulmonary complication in thoracic esophagectomy patients. Diseases of the Esophagus 2005 18 3 151 154 2-s2.0-29144522965 10.1111/j.1442-2050.2005. 00485.x (Pubitemid 41801108)
40. Paparella D., Yau T. M., Young E., Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. European Journal of Cardio-Thoracic Surgery 2002 21 2 232 244 2-s2.0-0036168128 10.1016/S1010-7940(01)01099-5 (Pubitemid 34135370)
41. Sablotzki A., Dehne M. G., Friedrich I., Grond S., Zickmann B., Mühling J., Silber R. E., Czeslick E. G., Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery. European Journal of Medical Research 2003 8 2 71 76 2-s2.0-0042662625
42. Apostolakis E. E., Koletsis E. N., Baikoussis N. G., Siminelakis S. N., Papadopoulos G. S., Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. Journal of Cardiothoracic Surgery 2010 5 1, article 1 2-s2.0-76949089043 10.1186/1749-8090-5-1
43. Dinarello C. A., Biologic basis for interleukin-1 in disease. Blood 1996 87 6 2095 2147 2-s2.0-0029979369 (Pubitemid 26086851)
44. Kelk P., Claesson R., Hänström L., Lerner U. H., Kalfas S., Johansson A., Abundant secretion of bioactive interleukin-1 β by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infection and Immunity 2005 73 1 453 458 2-s2.0-11144320656 10.1128/IAI.73.1. 453-458.2005 (Pubitemid 40041139)
45. Inoue K., Takano H., Shimada A., Yanagisawa R., Sakurai M., Yoshino S., Sato H., Yoshikawa T., Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Molecular Pharmacology 2005 67 3 673 680 2-s2.0-14944350369 10.1124/mol.104.005967 (Pubitemid 40365315)
46. Shao Y. M., Zhang L. Q., Deng L. H., Yao H. G., Clinical study on effects of ulinastatin on patients with systemic inflammatory response syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005 17 4 228 230 2-s2.0-54049091881
47. Lu X. Y., Zeng W. A., Lin W. Q., Chen B. X., He W. X., Effect of ulinastatin on inflammatory responses induced by oesophagectomy. Nan Fang Yi Ke Da Xue Xue Bao 2007 27 1 81 83 2-s2.0-43149089395
48. Nishiyama T., Hanaoka K., Do the effects of a protease inhibitor, ulinastatin, on elastase release by blood transfusion depend on interleukin 6? Critical Care Medicine 2001 29 11 2106 2110 2-s2.0-0035174029 (Pubitemid 33063537)
49. Park J. H., Kwak S. H., Jeong C. W., Bae H. B., Kim S. J., Effect of ulinastatin on cytokine reaction during gastrectomy. Korean Journal of Anesthesiology 2010 58 4 334 337 2-s2.0-77953431812 10.4097/kjae.2010.58.4.334
50. Tani T., Abe H., Endo Y., Hanasawa K., Kodama M., Effects of a urinary trypsin inhibitor on acute circulatory insufficiency after surgical operation. The American Journal of Surgery 1998 175 2 142 145 2-s2.0-0032007022 10.1016/S0002-9610(97)00263-8 (Pubitemid 28132905)
51. Hamazaki K., Matsubara N., Yunoki Y., Mori M., Mimura H., Orita K., Effects of ulinastatin on polymorphonuclear leukocyte elastase and interleukin 6 levels after hepatectomy. Clinical Therapeutics 1994 16 4 680 685 2-s2.0-0028033794 (Pubitemid 24321697)
52. Sato N., Endo S., Kimura Y., Ikeda K., Aoki K., Iwaya T., Akiyama Y., Noda Y., Saito K., Influence of a human protease inhibitor on surgical stress induced immunosuppression. Digestive Surgery 2002 19 4 300 305 2-s2.0-0036051160 10.1159/000064578 (Pubitemid 35013736)
53. Huang Y., Xie K., Zhang J., Dang Y., Qiong Z., Prospective clinical and experimental studies on the cardioprotective effect of ulinastatin following severe burns. Burns 2008 34 5 674 680 2-s2.0-44649141467 10.1016/j.burns.2007. 08.024
54. Park K. H., Lee K. H., Kim H., Hwang S. O., The anti-inflammatory effects of ulinastatin in trauma patients with hemorrhagic shock. Journal of Korean Medical Science 2010 25 1 128 134 2-s2.0-77949333197 10.3346/jkms.2010.25.1.128
55. Chen H., He M. Y., Li Y. M., Treatment of patients with severe sepsis using Ulinastatin and Thymosin α 1: a prospective, randomized, controlled pilot study. Chinese Medical Journal 2009 122 8 883 888 2-s2.0-68249138156 10.3760/cma.j.issn.0366-6999.2009.08.001
56. Inoue K., Takano H., Yanagisawa R., Yoshikawa T., Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide. Journal of Clinical Biochemistry and Nutrition 2008 43 3 139 142 2-s2.0-77951660671 10.3164/jcbn.2008059
57. Fang Y., Xu P., Gu C., Wang Y., Fu X., Yu W., Yao M., Ulinastatin improves pulmonary function in severe burn-induced acute lung injury by attenuating inflammatory response. Journal of Trauma-Injury, Infection and Critical Care 2011 71 5 1297 1304 2-s2.0-81455141331 10.1097/TA.0b013e3182127d48
58. Blackwood B., Murray M., Chisakuta A., Cardwell C. R., O'Halloran P., Protocolized versus non-protocolized weaning for reducing the duration of invasive mechanical ventilation in critically ill paediatric patients. Cochrane Database of Systematic Reviews 2013 7 CD009082
59. Tang C. W., Liu P. Y., Huang Y. F., Pan J., Lee S. S., Hsieh K., Liu Y., Ger L., Ventilator-associated pneumonia after pediatric cardiac surgery in southern Taiwan. Journal of Microbiology, Immunology and Infection 2009 42 5 413 419 2-s2.0-77749308563
60. Lin Y., Zhu X., Liu F., Zhao Y., Du J., Yao G., Li W., Jia X., Analysis of risk factors of prolonged intensive care unit stay of critically ill obstetric patients: a 5-year retrospective review in 3 hospitals in Beijing. Chinese Critical Care Medicine 2011 23 8 449 453 2-s2.0-80053533798 10.3760/cma.j.issn.1003-0603.2011.08.001
61. Silberman S., Bitran D., Fink D., Tauber R., Merin O., Very prolonged stay in the intensive care unit after cardiac operations: early results and late survival. Annals of Thoracic Surgery 2013 96 1 15 21 10.1016/j.athoracsur.2013. 01.103
62. Joskowiak D., Kappert U., Matschke K., Tugtekin S., Prolonged intensive care unit stay of patients after cardiac surgery: initial clinical results and follow-up. Thoracic and Cardiovascular Surgeon 2013 61 8 701 707 10.1055/s-0033-1347356
63. Whitlock R. P., Chan S., Devereaux P. J., Sun J., Rubens F. D., Thorlund K., Teoh K. H. T., Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. European Heart Journal 2008 29 21 2592 2600 2-s2.0-55749083074 10.1093/eurheartj/ehn333
64. Jia C. Y., Wang L., Mao Z. G., Zhang J. L., Zhang L., Combined myocardial injury markers for diagnosis of acute myocardial infarction. Sichuan Da Xue Xue Bao Yi Xue Ban 2009 40 6 1082 1085 2-s2.0-73049098897
65. Dawie J., Chawla R., Worku Y., Azazh A., Diagnosis of ischemic heart disease using CK-MB, troponin-i and ischemia modified albumin. Ethiopian Medical Journal 2011 49 1 25 33 2-s2.0-79953748345
66. Collinson P., Goodacre S., Gaze D., Gray A., Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial. Heart 2012 98 4 312 318 2-s2.0-84856227860 10.1136/heartjnl-2011- 300723
67. Yoo J. W., Ryu J. K., Lee S. H., Woo S. M., Park J. K., Yoon W. J., Lee J. K., Lee K. H., Hwang J., Kim Y., Yoon Y. B., Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas 2008 37 4 366 370 2-s2.0-58149153069 10.1097/MPA.0b013e31817f528f
68. Uemura K., Murakami Y., Hayashidani Y., Sudo T., Hashimoto Y., Ohge H., Sueda T., Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy. Journal of Surgical Oncology 2008 98 5 309 313 2-s2.0-53549093061 10.1002/jso.21098
69. Fujishiro H., Adachi K., Imaoka T., Hashimoto T., Kohge N., Moriyama N., Suetsugu H., Kawashima K., Komazawa Y., Ishimura N., Ishihara S., Amano Y., Kinoshita Y., Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. Journal of Gastroenterology and Hepatology 2006 21 6 1065 1069 2-s2.0-33744754140 10.1111/j.1440-1746.2006.04085.x (Pubitemid 43823296)
70. Levin R., Degrange M., Del Mazo C., Tanus E., Porcile R., Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Experimental and Clinical Cardiology 2012 17 3 125 130